These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24835327)

  • 81. 12-Month Coronary Angiography, Intravascular Ultrasound and Histology Evaluation of a Novel Fully Bioabsorbable Poly-L-Lactic Acid/Amorphous Calcium Phosphate Scaffolds in Porcine Coronary Arteries.
    Feng G; Xiao J; Bi Y; Lan Z; Zheng X; Lu Z; Li J; Wu K; Kislauskis E; McCarthy S; Hu Q; Jiang X; Wu T; Laham R
    J Biomed Nanotechnol; 2016 Apr; 12(4):743-52. PubMed ID: 27301200
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
    Sotomi Y; Onuma Y; Suwannasom P; Tateishi H; Tenekecioglu E; Zeng Y; Cavalcante R; Jonker H; Dijkstra J; Foin N; Koon JN; Collet C; de Winter RJ; Wykrzykowska JJ; Stone GW; Popma JJ; Kozuma K; Tanabe K; Serruys PW; Kimura T
    EuroIntervention; 2016 Oct; 12(8):e998-e1008. PubMed ID: 27721215
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bioresorbable Vascular Scaffold With Optimized Implantation Technique: Long-Term Outcomes From a Single-Center Experience.
    Albani S; Giannini F; Mitomo S; Fabris E; Mangieri A; Ponticelli F; Khokhar AA; Toselli M; Latib A; Colombo A
    J Invasive Cardiol; 2021 Feb; 33(2):E115-E122. PubMed ID: 33443487
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Bioresorbable vascular scaffolds in coronary chronic total occlusions: clinical, vasomotor and optical coherence tomography findings at three-year follow-up (ABSORB-CTO study).
    Gheorghe L; Millán X; Jimenez-Kockar M; Gomez-Lara J; Arzamendi D; Danduch L; Agudelo V; Serra A
    EuroIntervention; 2019 May; 15(1):99-107. PubMed ID: 30277460
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Monitoring in vivo absorption of a drug-eluting bioabsorbable stent with intravascular ultrasound-derived parameters a feasibility study.
    Bruining N; de Winter S; Roelandt JR; Regar E; Heller I; van Domburg RT; Hamers R; Onuma Y; Dudek D; Webster MW; Thuesen L; Ormiston JA; Cheong WF; Miquel-Hebert K; Veldhof S; Serruys PW
    JACC Cardiovasc Interv; 2010 Apr; 3(4):449-56. PubMed ID: 20398874
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial.
    Nakatani S; Onuma Y; Ishibashi Y; Muramatsu T; Iqbal J; Zhang YJ; van Geuns RJ; Ormiston JA; Serruys PW
    EuroIntervention; 2015 Mar; 10(11):1288-98. PubMed ID: 24572936
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Echogenicity as a surrogate for bioresorbable everolimus-eluting scaffold degradation: analysis at 1-, 3-, 6-, 12- 18, 24-, 30-, 36- and 42-month follow-up in a porcine model.
    Campos CM; Ishibashi Y; Eggermont J; Nakatani S; Cho YK; Dijkstra J; Reiber JH; Sheehy A; Lane J; Kamberi M; Rapoza R; Perkins L; Garcia-Garcia HM; Onuma Y; Serruys PW
    Int J Cardiovasc Imaging; 2015 Mar; 31(3):471-82. PubMed ID: 25627777
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice.
    Wiebe J; Hoppmann P; Cassese S; Rheude T; Colleran R; Kuna C; Rai H; Valeskini M; Ibrahim T; Joner M; Schunkert H; Laugwitz KL; Kastrati A; Byrne RA
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):584-590. PubMed ID: 32819850
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial.
    Okada K; Honda Y; Kitahara H; Ikutomi M; Kameda R; Brooke Hollak M; Yock PG; Popma JJ; Kusano H; Cheong WF; Sudhir K; Fitzgerald PJ; Kimura T;
    Int J Cardiol Heart Vasc; 2020 Dec; 31():100623. PubMed ID: 32944608
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Serial observation of drug-eluting absorbable metal scaffold: multi-imaging modality assessment.
    Waksman R; Prati F; Bruining N; Haude M; Böse D; Kitabata H; Erne P; Verheye S; Degen H; Vermeersch P; Di Vito L; Koolen J; Erbel R
    Circ Cardiovasc Interv; 2013 Dec; 6(6):644-53. PubMed ID: 24254708
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial.
    Gomez-Lara J; Salvatella N; Romaguera R; Brugaletta S; Ñato M; Roura G; Ferreiro JL; Teruel L; Gracida M; Sabate M; Vaquerizo B; Cequier À; Gomez-Hospital JA;
    EuroIntervention; 2020 Jun; 16(2):e155-e163. PubMed ID: 31217148
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
    Diletti R; Karanasos A; Muramatsu T; Nakatani S; Van Mieghem NM; Onuma Y; Nauta ST; Ishibashi Y; Lenzen MJ; Ligthart J; Schultz C; Regar E; de Jaegere PP; Serruys PW; Zijlstra F; van Geuns RJ
    Eur Heart J; 2014 Mar; 35(12):777-86. PubMed ID: 24394380
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.
    Karanasos A; Van Mieghem N; van Ditzhuijzen N; Felix C; Daemen J; Autar A; Onuma Y; Kurata M; Diletti R; Valgimigli M; Kauer F; van Beusekom H; de Jaegere P; Zijlstra F; van Geuns RJ; Regar E
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25969547
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Serial intravascular ultrasound evaluation of the DESolve™ novolimus-eluting bioresorbable coronary scaffold system.
    Barreira G; Costa JR; Costa R; Staico R; Chamie D; Slhessarenko JR; Tanajura LF; Abizaid A; Sousa A; Abizaid A
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):E368-E374. PubMed ID: 29521477
    [TBL] [Abstract][Full Text] [Related]  

  • 96. One-Year Results of Bioresorbable Vascular Scaffolds for Coronary Chronic Total Occlusions.
    Vaquerizo B; Barros A; Pujadas S; Bajo E; Jiménez M; Gomez-Lara J; Jacobi F; Salvatella N; Pons G; Cinca J; Serra A
    Am J Cardiol; 2016 Mar; 117(6):906-17. PubMed ID: 26874547
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Rationale and design: impact of intravascular ultrasound guidance on long-term clinical outcomes of everolimus-eluting stents in long coronary lesions.
    Cho S; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Contemp Clin Trials; 2015 Jan; 40():90-4. PubMed ID: 25433202
    [TBL] [Abstract][Full Text] [Related]  

  • 98. "Golden tube" with favorable vessel remodeling at four-year follow-up after bioresorbable vascular scaffold implantation for moderate to severe calcified lesions: Insights from intravascular imaging.
    Mitomo S; Candilio L; Tanaka A; Latib A; Colombo A
    Cardiol J; 2018; 25(4):532-533. PubMed ID: 30211931
    [No Abstract]   [Full Text] [Related]  

  • 99. Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy.
    Yahagi K; Virmani R; Kesavamoorthy B
    Cardiovasc Interv Ther; 2017 Jan; 32(1):53-55. PubMed ID: 26521263
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.